GSK (HAM:GS70) Total Current Liabilities: €25,868 Mil (As of Mar. 2026)


HAM:GS70 GSK PLC HAM:GS70
81 GF Score
Price €46.80
GF Value €38.60
! 2 Warning Signs
View Full Analysis

What is GSK Total Current Liabilities?

GSK HAM:GS70 +4.00% 81 Total Current Liabilities is €25,868 Mil as of Mar. 2026. GuruFocus rates HAM:GS70 with a GF Score™ of 81/100 and a GF Value™ of €38.60. The stock has 2 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. GSK's total current liabilities for the quarter that ended in Mar. 2026 was €25,868

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

GSK Total Current Liabilities Related Terms

GSK Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for GSK's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Total Current Liabilities Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27,856.32 26,227.33 24,454.88 26,195.49 24,455.04

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,894.93 23,972.49 24,562.93 24,455.04 25,868.11
HAM:GS70
81GF Score
GSK PLC HAM:GS70
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

GSK's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=5111.424+3443.438
+Other Current Liabilities+Current Deferred Liabilities
=15900.177+0
=24,455

GSK's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=17173.133+5817.413
+Other Current Liabilities+Current Deferred Liabilities
=2877.567+0
=25,868

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of €25,868 Mil mean?
GSK (HAM:GS70) has a Total Current Liabilities of €25,868 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for GSK and its competitors.
Is GSK's Total Current Liabilities too high?
GSK's current Total Current Liabilities is €25,868 Mil. Overall, GSK has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does GSK's Total Current Liabilities compare to LLY and JNJ?
GSK's Total Current Liabilities of €25,868 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Drug Manufacturers company?
A good Total Current Liabilities depends on the Drug Manufacturers industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for GSK and its competitors. GSK's current Total Current Liabilities is €25,868 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
GSK (HAM:GS70) has a current Total Current Liabilities of €25,868 Mil. The stock's GF Value™ is €38.60, compared to a current price of €46.80 — trading 21.2% above its estimated fair value. The current Total Current Liabilities is €25,868 Mil. GSK's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For GSK (HAM:GS70), the current Total Current Liabilities is €25,868 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (HAM:GS70) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of €46.80 is trading 21.2% above its estimated GF Value™ of €38.60.

Key valuation signals for HAM:GS70:

  • Total Current Liabilities: €25,868 Mil
  • GF Value™: €38.60 vs. price of €46.80 (21.2% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the HAM:GS70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
81GF Score

Get the complete analysis for HAM:GS70

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.80
Price
€38.60
GF Value